Billionaire restaurateur and casino operator reportedly pursuing $7 billion deal after surpassing rival bid
Billionaire entrepreneur Tilman Fertitta is reportedly in exclusive discussions to acquire Caesars Entertainment (CZR) in a deal valued at approximately $7 billion, according to individuals familiar with the negotiations. The potential transaction comes after Fertitta’s offer surpassed a competing bid from an investment firm associated with billionaire investor Carl Icahn, positioning Fertitta as the leading contender for the casino operator.
Fertitta, the chairman and chief executive of Fertitta Entertainment, has been in talks to purchase Caesars shares at roughly $34 per share, a premium that reflects confidence in the company’s long-term prospects within the global gaming and hospitality industry. Caesars Entertainment is one of the largest casino operators in the United States, with an extensive portfolio of gaming properties, hotels, and entertainment venues across several major markets.
The acquisition would significantly expand Fertitta’s presence in the gaming sector. Fertitta Entertainment already operates numerous hospitality and gaming assets, including the well-known Golden Nugget casinos, along with a broad portfolio of restaurants and entertainment businesses. Adding Caesars to the company’s holdings would create one of the most powerful privately controlled gaming groups in the industry.
The exclusive negotiations suggest that Fertitta has emerged as the preferred buyer after outbidding Icahn’s investment group, though the deal has not yet been finalized and terms could still change. Market observers note that large-scale consolidation in the casino industry has accelerated in recent years as companies seek to expand their geographic reach and strengthen their digital gaming platforms.
Investors are closely watching the talks, as a transaction of this magnitude could reshape the competitive landscape for casino operators in North America and beyond. If completed, the acquisition would represent one of the largest deals in the gaming industry in recent years, further cementing Fertitta’s status as a major force in hospitality, entertainment, and casino operations.
You might like this article:Acurx Pharmaceuticals Shares Rise on New Clinical Trial Plans
